What is a stock summary page? Click here for an overview.
Business Description
Onconetix Inc
NAICS : 541713
SIC : 2834
ISIN : US09610B1089
Description
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -4.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -144.5 | |||||
| 3-Year EPS without NRI Growth Rate | -96.2 | |||||
| 3-Year FCF Growth Rate | -71.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.18 | |||||
| 9-Day RSI | 17.02 | |||||
| 14-Day RSI | 20.52 | |||||
| 3-1 Month Momentum % | -20.31 | |||||
| 6-1 Month Momentum % | -94.85 | |||||
| 12-1 Month Momentum % | -95.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 69.04 | |||||
| Days Sales Outstanding | 32.79 | |||||
| Days Payable | 561.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.4 | |||||
| Shareholder Yield % | 23.59 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -39.14 | |||||
| Operating Margin % | -840.64 | |||||
| Net Margin % | -2759.57 | |||||
| FCF Margin % | -744.17 | |||||
| ROA % | -82.75 | |||||
| ROIC % | -22.1 | |||||
| 3-Year ROIIC % | -17.74 | |||||
| ROC (Joel Greenblatt) % | -29097 | |||||
| ROCE % | -115.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.04 | |||||
| PB Ratio | 0.03 | |||||
| EV-to-EBIT | -0.37 | |||||
| EV-to-EBITDA | -0.37 | |||||
| EV-to-Revenue | 9.86 | |||||
| EV-to-FCF | -1.32 | |||||
| Earnings Yield (Greenblatt) % | -270.27 | |||||
| FCF Yield % | -889.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ONCO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onconetix Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.87 | ||
| EPS (TTM) ($) | -99.52 | ||
| Beta | 3.31 | ||
| 3-Year Sharpe Ratio | -1.46 | ||
| 3-Year Sortino Ratio | -1.59 | ||
| Volatility % | 127.04 | ||
| 14-Day RSI | 20.52 | ||
| 14-Day ATR ($) | 0.037556 | ||
| 20-Day SMA ($) | 0.16333 | ||
| 12-1 Month Momentum % | -95.32 | ||
| 52-Week Range ($) | 0.0871 - 21.4 | ||
| Shares Outstanding (Mil) | 14.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onconetix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onconetix Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onconetix Inc Frequently Asked Questions
What is Onconetix Inc(ONCO)'s stock price today?
The current price of ONCO is $0.11. The 52 week high of ONCO is $21.40 and 52 week low is $0.09.
When is next earnings date of Onconetix Inc(ONCO)?
The next earnings date of Onconetix Inc(ONCO) is 2025-05-20 Est..
Does Onconetix Inc(ONCO) pay dividends? If so, how much?
Onconetix Inc(ONCO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers